Previously, Hogarth et al. found that BCL2 expression and the BCL2/BAX ratio had no prognostic significance in children with ALL, whereas a high expression of BAX at diagnosis was associated with a significant increase in the probability of relapse (24). This evidence concerns the gene BAX and acute lymphoblastic leukemia.